PEN News and Press, Penumbra Inc. From 01/26/23

Penumbra, Inc. Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 23, 2023 PR Newswire ALAMEDA, Calif. , Jan. 26, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to dis...

Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Higher interest rates created a difficult year for ...

Summary Healthcare significantly outperformed the broader market last year, after two years of underperforming the S&P 500. When the end to restrictive policy is in sight, then the sector is likely to witness a group rotation to more growth-oriented stocks. Groups like medical d...

Summary Penumbra has benefited from renewed enthusiasm around the company's neuro and peripheral thrombectomy platforms, and the company recently launched the Lightning Flash. Management is making a big bet on computer-aided aspiration for benefits like shorter procedure times and impro...

PENUMBRA LAUNCHES LATEST INNOVATION IN MECHANICAL THROMBECTOMY: LIGHTNING FLASH™ PR Newswire Lightning Flash™ is the most advanced mechanical thrombectomy system on the market to address venous and pulmonary thrombus Next generation technology combines s...

Summary BMEZ’s portfolio has a combination of unknown small-cap "next generation" healthcare holdings and some familiar names in the field of biotechnology. Lack of diversification makes BMEZ susceptible to sector-specific risk. It also has a relatively high expense ratio despite...

Summary AngioDynamics posted a pretty clean fiscal second quarter that was a little better than the sell-side expected, and that seemed to drive a meaningful relief rally for the beaten-down shares. Lackluster results from AngioVac/AlphaVac bear watching, given that they're important gr...

Penumbra, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference PR Newswire ALAMEDA, Calif. , Dec. 19, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 41 st Annual J.P. Mor...

Latest REAL y-Series™ is the only hands-free, non-tethered virtual reality rehabilitation platform to address both upper and lower extremities with a full body avatar Clinicians can customize exercises and activities to challenge, motivate and engage patients, and track ful...

Penumbra, Inc. (PEN) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Jee Hamlyn-Harris – Investor Relations Adam Elsesser – Chairman and Chief Executive Officer Sandra Lesenfants – President-Interventional ...